GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Return-on-Tangible-Equity

Cybin (CYBN) Return-on-Tangible-Equity : -414.36% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cybin's annualized net income for the quarter that ended in Dec. 2023 was $-90.43 Mil. Cybin's average shareholder tangible equity for the quarter that ended in Dec. 2023 was $21.82 Mil. Therefore, Cybin's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -414.36%.

The historical rank and industry rank for Cybin's Return-on-Tangible-Equity or its related term are showing as below:

CYBN' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -311.86   Med: -120.53   Max: -103.11
Current: -311.86

During the past 4 years, Cybin's highest Return-on-Tangible-Equity was -103.11%. The lowest was -311.86%. And the median was -120.53%.

CYBN's Return-on-Tangible-Equity is ranked worse than
91.85% of 1301 companies
in the Biotechnology industry
Industry Median: -46.42 vs CYBN: -311.86

Cybin Return-on-Tangible-Equity Historical Data

The historical data trend for Cybin's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Return-on-Tangible-Equity Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Return-on-Tangible-Equity
- -103.35 -120.05 -129.60

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -141.22 -247.18 -422.41 -339.02 -414.36

Competitive Comparison of Cybin's Return-on-Tangible-Equity

For the Biotechnology subindustry, Cybin's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cybin's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Cybin's Return-on-Tangible-Equity falls into.



Cybin Return-on-Tangible-Equity Calculation

Cybin's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=-34.707/( (40.427+13.135 )/ 2 )
=-34.707/26.781
=-129.60 %

Cybin's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-90.428/( (13.181+30.466)/ 2 )
=-90.428/21.8235
=-414.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Cybin  (AMEX:CYBN) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Cybin Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Cybin's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Industry
Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.